% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • larshansson18 larshansson18 May 1, 2012 4:24 AM Flag

    why will doctors not prescribe ceplene

    Sales acctually started in January.

    I think we have a strategic struggel between Meda and Epicept, the one who affords waiting wins, so to speak.

    The results from the post-approval study out later this spring? One of the cards to be played. A factorial trial without M2 will be a success, I think. Sell the US market to another CO.

    Amiket gives Ceplene a new context, no need for a rush here (that is from Epicepts perspectiv. Patients perspectiv, hm.)

0.34-0.03(-8.13%)Jul 22 3:59 PMEDT